Charity registration number: 1168682
PROSTATE CYMRU TRUSTEES' REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
Prostate Cymru Contents
| Page | |
|---|---|
| Trustees' Report | 1—8 |
| Independent Examiner's Report | 9 |
| Statement of Financial Activities | 10 |
| Comparative Statement of Financial Activities | 11 |
| Statement of Financial Position | 12 |
| Statement of Cash Flows | 13 |
| Notes to the Statement of Cash Flows | 14 |
| Notes to the Financial Statements | 15—22 |
Trustees' Report For The Year Ended 31 December 2025
Prostate Cymru
The trustees present their report and the financial statements for the year ended 31 December 2025.
Objectives and Activities
Aims and Objectives
Welcome from our Chair
On behalf of the Trustees, I am pleased to present the Trustees Annual Report and Financial Statement for the year ending 31st December 2025.
This document captures another year of significant milestones for our organisation as we continue our vital work as the leading prostate health charity in Wales.
My sincere thanks go to my fellow Trustees, David Brace OBE, Lyn Murray, John Daniels, Ian Barwick, Andrew Hill, and James Trafford. Their steadfast dedication, passion, and commitment remain the foundation of our governance.
As a board, we are immensely proud to reflect on the progress made over the past twelve months. The strategic goals established at the start of the year have largely come to fruition, a testament to the collective efforts and unwavering commitment of our entire team.
This continued success has been expertly guided by our Chief Executive, Tina Tew. Her leadership remains instrumental in navigating the unique challenges of the sector and driving our mission forward with clarity and purpose.
Our gratitude also extends to the core staff team, Owen Pugsley, Rebecca Havard, Lydia Caunce, Ellen Jug, and Phoebe Williams. Their enthusiasm and dedication are the cornerstones of our success. Their ability to embrace new challenges with determination continues to be inspiring and has undoubtedly elevated our impact across Wales. I would also like to welcome Fiona Sheppard who joined the team In July to project manage the Charity’s ambitious Walk of Wales Challenge in 2026.
The heartbeat of our charity lies within our Friendship Groups currently located in Brecon, Cardiff & Vale, Carmarthenshire, Ceredigion, Pembrokeshire, Mid Glamorgan and Rhondda Cynon Taf.
These groups are the backbone of our community engagement, fostering vital connections and spreading awareness in their respective regions. Alongside them, our awareness team members deserve special recognition for generously volunteering their time to champion our cause.
Furthermore, we thank our health professional Gaynor Newton for her tireless dedication to assisting men and their families. Her expertise and support via the nurse hotline provide a lifeline to those navigating prostate health concerns.
With the continued support of our community, we have achieved extraordinary milestones this year and laid the groundwork for even greater reach in the future.
Thank you for the profound difference you make to the health and well-being of the men in Wales.
James Andrew Thomas - Chairman
...CONTINUED
Page 1
Prostate Cymru Trustees' Report (continued) For The Year Ended 31 December 2025
Aims and Objectives - continued
In a year where the economic climate remained challenging for many, Prostate Cymru has continue to grow, with annual income reaching £797,013. We have continued to carefully monitor our overheads, ensuring that operational costs are kept to a minimum to allow more resources to be allocated to our charitable objectives.
Prostate Cymru has continued to prosper throughout 2025. This report outlines the financial performance and activities for the financial year ending 31st December 2025. As a Charitable Incorporated Organisation (CIO), our core objects remain:
Providing support, education, and practical advice. Advancing public education in all areas relating to prostate problems. Promoting and influencing effective care and support for those affected.
With over 2,500 new diagnoses annually in Wales and a 1 in 8 risk for men, our mission is more critical than ever. We remain dedicated to fostering a deeper understanding of prostate disease across the Welsh population.
Significant Activities
FUNDRAISING AND EVENTS
As a charity that relies entirely on voluntary donations, Prostate Cymru continues to be humbled by the extraordinary creativity and resourcefulness of our supporters. Throughout 2025, our income reached a record £797,013, a milestone driven by an inspired range of community activities—from traditional lunches and concerts to more adventurous and gruelling physical challenges. This financial success is a direct reflection of the deepening connection between the charity and the Welsh public, further evidenced by a significant surge in digital engagement and social media interactions across our website, Instagram, and Facebook platforms.
Our reach also expanded through the vital support of the business community. We are privileged to work with a diverse range of corporate partners, as well as voluntary organisations such as the Rotary and Freemasons. Our thanks also go to the many rugby, football, and cricket clubs whose members consistently go above and beyond to support our mission.
The 2025 event calendar began with a spectacular evolution of the Blue Tie Ball. Moving to a new location at the Parkgate Hotel in Cardiff, the event was bigger and more prestigious than ever before. It served as a vital hub for our community, bringing together supporters and Friendship Groups from across the nation to celebrate nominees from every corner of Wales. The evening successfully balanced a sense of fun and celebration, with the core mission of recognising those who have gone above and beyond for the charity.
The charity's sporting fixtures also reached new heights this year. The Cardiff Marathon saw a record-breaking contingent of over 170 runners sporting the Prostate Cymru colours, resulting in a bumper fundraising total that exceeded all previous expectations. This momentum was mirrored in our other flagship events, including the Five Valleys Sportive, which saw a significant increase in participation, and our expanded schedule of Big Walks. These events continue to be essential not only for revenue but for maintaining a visible, active presence in the community
Golf remains a cornerstone of Prostate Cymru’s fundraising calendar, providing not only vital financial support but also a powerful platform for community engagement and awareness. We are incredibly grateful to the many golf club captains across Wales and our corporate supporters who continue to choose Prostate Cymru as their beneficiary.
The Ray Murray Golf Day remains a standout event in our annual schedule. In 2025, it was once again a resounding success, bringing together regular golfers and corporate partners for a day of spirited competition and camaraderie. We extend our heartfelt thanks to the Murray family for their unwavering support and presence, which ensures this event remains a highlight for all involved and an opportunity to remember where it all began, the brainchild of our founding Chairman, the late Ray Murray.
Another golfing event, in September, marked a poignant milestone with the third and final golf day held in memory of our much-loved ambassador, Eddie Butler.
Also in September, a dedicated team of Prostate Cymru supporters took on the challenge of the Namibian dessert. Building on the previous success this marked our second major trek in recent years, with many of the original team who previously conquered Machu Picchu returning to join us across the African terrain. Navigating some of the world's most dramatic desert landscapes, our trekkers demonstrated immense physical grit and shared determination. Beyond raising tens of thousands of pounds to fund our ongoing work across Wales, this bucket-list expedition fostered a powerful sense of community among participants, shining a spotlight on prostate health awareness on a wider stage.
...CONTINUED
Page 2
Prostate Cymru Trustees' Report (continued) For The Year Ended 31 December 2025
Significant Activities - continued
AWARENESS AND PUBLIC EDUCATION
Prostate Cymru has seen an unprecedented surge in public engagement, driven by both high-profile national conversations and our own expanding schedule of awareness activity. As a charity, our primary mission remains the advancement of public education regarding prostate health.
Following a recruitment drive, training sessions were held with new volunteers to equip them with the knowledge and confidence to present key information on prostate health and share our key awareness messages to men across Wales.
We know that reaching men where they spend most of their time is the most effective way to break down the barriers surrounding prostate health. That is why our workplace awareness talks are the foundation of our engagement strategy. These sessions provide a safe, neutral space for men to learn about their personal risk factors—such as age, ethnicity, and family history—in a setting that feels accessible and professional.
By partnering with Welsh businesses to deliver these vital educational sessions, we help employees move past stigma and hesitation, equipping them with the knowledge to make informed decisions about their health.
The landscape of prostate cancer awareness was significantly impacted this year by the high-profile diagnosis of Sir Chris Hoy. His courage in sharing his personal journey resonated deeply across the United Kingdom, leading to a marked increase in public inquiries and a renewed, urgent call for a National Screening program. This national dialogue has intensified our efforts, as we continue to highlight the critical importance of early diagnosis in improving survival rates.
A defining achievement of 2025 has been the successful expansion of the Prostate Cymru PSA Testing Programme. Following a successful pilot, the charity launched a comprehensive community schedule across Wales to dismantle the barriers men often face when seeking testing through primary care. By providing a streamlined, accessible service, we have empowered a record number of men to take a proactive stance on their health.
The 2025 initiative targeted locations across Wales where our Friendship Groups are most active. This community-focused approach resulted in over 3,000 tests being administered in key hubs including Kenfig Hill, Cowbridge, Brecon, Swansea, Cardiff, Carmarthen, Narberth, and Aberystwyth. The clinical data from these sessions underscores the life-saving potential of the programme:
-
Early Detection: Of the men tested, 6% received "red" results, indicating an abnormal PSA score that required immediate clinical investigation.
-
Peace of Mind: For the remaining 94% the tests returned "green" results, providing them with essential peace of mind and a vital baseline for future health monitoring.
-
Breaking Barriers: Our evaluations revealed that for over 1,000 participants, this was their first-ever PSA test, and nearly 700 men had never even heard of the PSA test prior to attending our event.
The widespread public engagement surrounding the launch of our programme highlighted a clear demand for equal access across all parts of the nation, particularly within North Wales communities. Working in close partnership with local prostate cancer support groups, we expanded the schedule by adding two dedicated testing dates in Colwyn Bay and Llangefni. Operating under the same community testing framework, these events ensured that our preventative health interventions reached men in North Wales
This large-scale operation was made possible through a collaborative funding model. We are deeply grateful to our sponsors —including Swansea Building Society, Alan Petersen, The Dunraven Group, Enterprise Holdings, the Royal Warrant Office, and JCP Solicitors, whose contributions allowed us to offer the service for a modest £10 donation.
We would also like to thank the numerous venues and community hubs across Wales that provided their facilities free of charge. This collective spirit of cooperation ensured that the maximum possible resource was directed where it mattered most: providing life-saving information to the men of Wales.
SUPPORTING MEDICAL PROFESSIONALS
Applications for the Ray Murray and Ray Williams bursaries continue to decline, with only one application granted in 2025. The current cost-of-living crisis and rising travel expenses have made the logistics of organising a specialised urological elective, particularly those involving international placements, a daunting financial and administrative hurdle for many students. Prostate Cymru’s bursary scheme will remain in place, and it is hoped that focus on promoting urology as a vital specialty will drive a new wave of applicants.
In memory of our late ambassador, the legendary Eddie Butler, the Eddie Butler PhD Studentship represents a landmark investment in the future of prostate cancer research in Wales. Established in partnership with Cardiff University, this prestigious studentship is currently supporting vital research at the European Cancer Stem Cell Research Institute. Under the expert supervision of Dr. Helen Pearson, the project focuses on the molecular mechanisms of prostate cancer progression, seeking to identify the "off switch" for aggressive tumours.
...CONTINUED
Page 3
Prostate Cymru Trustees' Report (continued) For The Year Ended 31 December 2025
Significant Activities - continued
As this studentship concludes, we are proud to ensure that Eddie’s name lives on through the introduction of a prestigious annual award. The Eddie Butler Award will be presented to an individual or group who has demonstrated exceptional dedication by going above and beyond in a voluntary capacity to champion the charity’s cause.
Prostate Cymru continues to support the advancement of care within NHS Wales. Our significant £120,000 grant to the Swansea Bay Health Board funded the appointment of Surgical Cancer Specialist Kelly Crowe, who is pivotal to the region’s growing robotic surgery programme. This initiative builds upon our previous investments in the Da Vinci robotic system, which enables minimally invasive procedures with reduced recovery times and improved precision for Welsh patients.
Public Benefit
Significant activities undertaken in the service of public benefit are as noted above.
The trustees confirm that they have complied with the requirements of Section 17 of the Charities Act 2011 to have due regard to the Charity Commission’s guidance on public benefit.
Achievements and Performance
Main Achievements
The charity significantly strengthened its revenue through a marked increase in participation across our flagship fundraising events. Key successes this year include The Cardiff Half Marathon, The Five Valleys Sportive, Big Breakfast initiative, the Ray Murray golf day and our expanded schedule of Big Walks.
This surge in community involvement has bolstered our capacity to sustain and expand our initiatives.
In terms of public relations, we have seen a substantial increase in followers and interactions across our social media channels, including our website, Instagram, and Facebook. This digital growth has allowed us to reach more individuals than ever before, providing vital tools such as our advice line and health assessment form.
Our Friendship Groups remain a vital pillar for community engagement and prostate health awareness. Our ambition is to establish further groups and conversations are taking place with interested parties in Swansea, Abergavenny, Monmouthshire, and North Wales.
These would complement our existing active groups across Brecon, Cardiff and Vale, Carmarthenshire, Ceredigion, Mid Glamorgan, Pembrokeshire, and Rhondda Cynon Taf. Our goal remains to ensure every corner of Wales receives the support and information it needs to champion prostate health.
Looking ahead to 2025
Raising awareness remains our priority. We are constantly seeking new partnerships and forging connections with local leaders and healthcare professionals to overcome the barriers that keep men from taking proactive action.
To strengthen our direct clinical and patient support services across Wales, 2026 will see the appointment of our second Specialist Nurse, Sharon Havard. Sharon will join our established health professional Gaynor Newton, significantly increasing our capacity to provide expert guidance, practical advice, and vital emotional support to men and families navigating a prostate cancer diagnosis.
We plan to further expand our PSA testing programme. We will prioritise accessibility for those in the greatest need, specifically targeting rural communities and regions with diverse populations to ensure that no group is left behind. Through careful planning and collaborative partnerships, we will ensure this expansion does not compromise the quality of service, remaining steadfast in our commitment to pioneering prostate cancer care in Wales.
We plan to expand the PSA test programme for the second year since its initial pilot, our strategy will continue to prioritise accessibility for those in the greatest need. Targeting areas of deprivation, rural communities, and regions with diverse populations is essential to ensure that no group is left behind. This targeted approach recognises the structural barriers that often hinder engagement with preventative healthcare and seeks to address them directly.
While scaling up our initiative, it is essential to acknowledge the financial implications and the potential strain on existing resources. Careful planning will be required to ensure that the expansion does not compromise the quality of service. Exploring opportunities for external funding, collaborative partnerships, and volunteer involvement can help mitigate these pressures.
...CONTINUED
Page 4
Prostate Cymru Trustees' Report (continued) For The Year Ended 31 December 2025
Looking ahead to 2025 - continued
As we look forward into 2026, our focus sharpens onto an incredibly ambitious challenge, The Walk of Wales. Led by Prostate Cymru Chairman, Andy Thomas, this gruelling 1,012-mile, 44-day challenge will see the team walk the full circumference of Wales along the Coastal Path and Offa’s Dyke Path, starting and finishing in Cardiff. Far more than a feat of physical endurance, this monumental trek will serve as the active vehicle to deliver, integrate, and achieve our core strategic objectives for the coming year.
As the walk navigates the nation, the team will constantly seek new partnerships, forging direct connections with local leaders and healthcare professionals in every region. By meeting communities where they are, we aim to break down the traditional stigmas and communication barriers that keep men from taking proactive action regarding their prostate health.
While traditional community events remain vital, our 2026 strategy focuses heavily on scaling our impact through corporate partnerships. We will leverage the massive profile of the Walk of Wales to engage businesses along the route, utilising their extensive networks to reach entirely new and targeted audiences.
The impact of our volunteer Friendship Groups cannot be overstated; they bring a sense of community and shared purpose. These groups will act as regional anchors during the walk—hosting events, rallying supporters and offering local vital knowledge.
The ultimate goal of this unified effort is to hit an ambitious fundraising target of £300,000, with every single penny raised being directly invested into funding six specialist NHS prostate cancer nurses across the Welsh Health Boards. These specialist roles will transform the patient pathway in Wales, providing consistent, personalised support from initial diagnosis through to treatment and recovery.
Financial Review
Financial Position
Prostate Cymru operates independently without any central or government funding. We rely entirely on self-financing methods, including staff-led fundraising events, the tireless work of our Friendship Groups, dedicated volunteers, and public donations. This year, the charity's financial position remains favourable due to prudent resource management and a steadfast commitment to our core objectives. For the current year ending 2025, our incoming resources reached a record £797.013, building upon the £514,673 reported in 2024.
Our core administrative and fundraising functions are managed by a small, dedicated team of part-time and full-time staff. This team consistently demonstrates exceptional flexibility, often working beyond contracted hours to ensure the successful delivery of critical projects and events. Their efforts are bolstered by our volunteers, whose participation allows the charity to broaden its reach and effectiveness without significantly increasing operational costs.
During the year the charity’s incoming resources amounted to £514,673 (2023: £586,043) and resources expended amounted to £561,972 (2023: £463,084).
The charity became a charitable incorporated organisation (CIO) on 9th August 2017. The net assets transferred totalled £490,057.
Over the past year, the charity has retained its level of income, effectively managed its expenditure, leading to a positive and financially rewarding outcome.
The charity operates independently without central or government funding, relying entirely on self-financing methods such as staff-led fundraising events, friendship groups, volunteers and public donations.
The core administrative and fundraising functions are managed by a small team, composed of both part-time and full-time staff members, who regularly commit to working beyond their contracted hours, demonstrating exceptional flexibility and dedication. This dedication enables the successful delivery of the charity’s projects and events, ensuring all critical roles are fulfilled efficiently.
In addition to staff efforts, volunteers play a crucial part in supporting a range of activities, from events to community outreach. The combined workforce allows the charity to broaden its reach and effectiveness without significantly increasing operational costs.
In summary, the charity’s financial position remains favourable, with prudent resource management and a strong commitment to its objectives and service quality.
Page 5
Prostate Cymru Trustees' Report (continued) For The Year Ended 31 December 2025
Risk Management
The primary and ongoing risk to the charity remains our reliance on self-financing due to the lack of central funding or government grants. This structural vulnerability is highlighted and managed continuously by the trustees, as our operational capability depends entirely on the sustained efforts, fundraising ingenuity, and goodwill of our many stakeholders.
Recognising the highly competitive nature of the modern charity sector, it is imperative that Prostate Cymru actively works to increase public support. Our current mitigation strategy balances the retention of our existing, deeply valued support base with the enrolment of new donors, the development of robust business links, and the continuous creation of innovative sporting challenges and community events to attract fresh support.
We are fortunate to have a dedicated cohort of high-profile Ambassadors and corporate partners who passionately champion our cause. In an increasingly digital landscape, these partners effectively utilise their influence and vast social media networks to amplify our message.
To further insulate the charity against funding fluctuations, our strategic focus remains on the expansion of both our corporate supporters and our volunteer Friendship Groups. These networks are vital for maintaining a consistent stream of income and fostering grassroots engagement directly through corporate workforces and local communities.
To ensure maximum financial resilience, the charity upholds a tradition of detailed financial management. All operational and project expenditure undergoes rigorous and ongoing scrutiny to ensure cost-effectiveness and a direct alignment with our core charitable objectives.
Future Developments
The national decision to restrict routine testing was a major disappointment, leaving many high-risk men in Wales without a clear proactive safety net. We believe that limiting early detection relies on outdated clinical views that ignore just how safe, precise, and vital modern diagnostics have become.
Prostate Cymru refuses to let Welsh men be left behind by outdated policies. Rather than waiting for national guidelines to catch up, we are taking matters into our own hands to protect Welsh men. To ensure no man in Wales is left behind, our strategy focuses on three critical pillars of education and advocacy:
-
Empowering Men to Make Informed Choices: Catching prostate cancer early relies heavily on a man being proactive, but he needs the right facts to do so. We are expanding our workplace awareness tours and community outreach to teach men exactly what their risk factors are—especially regarding age, family history, and ethnicity. By providing clear, jargon-free information, we give the male population across Wales the confidence to understand their bodies and make informed choices about asking for a PSA test.
-
Educating and Supporting GPs: A major hurdle for many men is facing difficulties or hesitation when asking their primary care doctor for a PSA blood test. We are committed to working closely with healthcare professionals across Wales, providing updated education and resources for GPs. By ensuring doctors are fully aware of modern, noninvasive triage methods—such as the pre-biopsy MRI—we can dismantle old barriers and ensure men are not refused or dissuaded from taking a vital, five-minute baseline test.
-
Challenging Outdated Guidelines with the Welsh Government: The current National Institute for Health and Care Excellence (NICE) guidelines surrounding routine PSA testing are outdated and do not fully reflect the safety, accuracy, and targeted nature of modern diagnostics. Moving forward, Prostate Cymru will actively lobby and collaborate with the Welsh Government to review these guidelines. Wales has the opportunity to lead the way by adopting a more proactive, targeted screening framework ultimately saving lives through earlier, smarter intervention.
Structure, Governance and Management
Governing Document
The charity's governing document is that of a CIO foundation that was registered on 9th August 2016.
The charity is charitable incorporated organisation registered with the Charity Commission.
Trustee Selection Methods
Apart from the first charity trustees, every trustee must be appointed for a term of three years by a resolution passed at a properly convened meeting of the charity trustees. In selecting individuals for appointment as charity trustees, the charity trustees must have regard to the skills, knowledge and experience needed for the effective administration of the CIO.
The Trustees seek to ensure that the needs of the Charity are appropriately reflected through the diversity of its board.
Page 6
Prostate Cymru Trustees' Report (continued) For The Year Ended 31 December 2025
Induction and Training of Trustees
New trustees will receive an induction pack, a handbook with a copy of the governing document and all the policies and procedures adopted by the board. The Trustees are also encouraged to attend suitable training seminars conducted by the Charity’s accountants and legal advisors from time to time.
Key Management Remuneration
The trustees and the senior management team comprise the key management personnel of the charity in charge of directing and controlling, running and operating the charity on a day to day basis. All trustees give of their time freely and no trustee received remuneration in the year. Details of trustees’ expenses, key management personnel and related party transactions are disclosed in the notes to the accounts. The salary for the key management personnel is determined by benchmarking the rates against the current market.
Related Parties
The Pembrokeshire and Carmarthenshire Friends are wholly affiliated to Prostate Cymru in support of achieving its objects.
Reference and Administrative Details
Trustees
Mr J Daniels Mr A D Hill Dr I Barwick Mr J Trafford Mr D Brace OBE Mrs M L Murray Dr J A Thomas - Chair
Other Personnel
Tina Tew - Chief Executive Officer
Charity Number
1168682
Principal Address
12, Drake Walk Waterfront 2000 Cardiff CF10 4AN
Independent Examiner
HLS Accounting Limited ACCA
Page 7
Prostate Cymru Trustees' Report (continued) For The Year Ended 31 December 2025
Statement of Trustees' Responsibilities
The trustees are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
The law applicable to charities in England and Wales requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources of the charity for that period. In preparing the financial statements the trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles in the Charity SORP;
-
make judgments and accounting estimates that are reasonable and prudent;
-
state whether applicable accounting standards have been followed; subject to any departures disclosed and explained in the financial statements; and
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business.
The trustees are responsible for keeping adequate accounting records which disclose with reasonable accuracy at anytime the financial position of the charity and to enable them to ensure that the accounts comply with the Charities Act 2011, the Charities (Accounts and Reports) Regulations 2008 and the provisions of the trust deed. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charity's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
The trustees' report was approved by the board of trustees and signed on its behalf by:
Dr J A Thomas
Trustee 21 September 2026
Page 8
Prostate Cymru Independent Examiner's Report to the Trustees of Prostate Cymru For The Year Ended 31 December 2025
I report to the trustees on my examination of the accounts of Prostate Cymru (the Trust) for the year ended 31 December 2025.
Responsibilities and Basis of Report
As the charity trustees of the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (“the Act”).
I report in respect of my examination of the Trust’s accounts carried out under section 145 of the 2011 Act and in carrying out my examination, I have followed the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.
Independent Examiner's Statement
Since the Trust’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of The Association of Chartered Certified Accountants, which is one of the listed bodies.
I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
accounting records were not kept in respect of the Trust as required by section 130 of the Act; or
-
the accounts do not accord with those records; or
-
the accounts do not comply with the applicable requirements concerning the form and contents of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a 'true and fair view' which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
HLS Accounting Limited ACCA 30 September 2026
Page 9
Prostate Cymru Statement of Financial Activities For The Year Ended 31 December 2025
| Notes INCOME AND ENDOWMENTS FROM: Donations and legacies 3 Other trading activities 4 Investments 5 EXPENDITURE ON: Raising funds 7 Charitable activities 7 NET INCOME/(EXPENDITURE) NET MOVEMENT IN FUNDS RECONCILIATION OF FUNDS: Total funds brought forward TOTAL FUNDS CARRIED FORWARD 19 |
2025 Unrestricted funds £ 405,793 378,119 13,101 |
2024 Total funds £ 295,474 204,621 14,578 |
|---|---|---|
| 797,013 | 514,673 | |
| (180,424) (589,087) |
(135,903) (426,070) |
|
| (769,511) | (561,973) | |
| 27,502 | (47,300) | |
| 27,502 964,731 |
(47,300) 1,012,031 |
|
| 992,233 | 964,731 |
The notes on pages 14 to 22 form part of these financial statements.
Page 10
Prostate Cymru Comparative Statement of Financial Activities For The Year Ended 31 December 2025
| Notes INCOME AND ENDOWMENTS FROM: Donations and legacies 3 Other trading activities 4 Investments 5 EXPENDITURE ON: Raising funds 7 Charitable activities 7 NET EXPENDITURE NET MOVEMENT IN FUNDS RECONCILIATION OF FUNDS: Total funds brought forward TOTAL FUNDS CARRIED FORWARD 19 |
Unrestricted funds £ 295,474 204,621 14,578 |
Restricted funds £ - - - |
2024 Total funds £ 295,474 204,621 14,578 |
|---|---|---|---|
| 514,673 | - | 514,673 | |
| (135,903) (424,530) |
- (1,540) |
(135,903) (426,070) |
|
| (560,433) | (1,540) | (561,973) | |
| (45,760) | (1,540) | (47,300) | |
| (45,760) 1,010,491 |
(1,540) 1,540 |
(47,300) 1,012,031 |
|
| 964,731 | - | 964,731 |
The notes on pages 14 to 22 form part of these financial statements.
Page 11
Prostate Cymru Statement of Financial Position As At 31 December 2025
| Notes FIXED ASSETS Tangible Assets 15 CURRENT ASSETS Debtors 16 Cash at bank and in hand Creditors: Amounts Falling Due Within One Year 17 NET CURRENT ASSETS (LIABILITIES) TOTAL ASSETS LESS CURRENT LIABILITIES NET ASSETS FUNDS OF THE CHARITY Unrestricted Funds TOTAL FUNDS 19 |
Unrestricted funds £ 79,923 |
Restricted funds £ - |
2025 Total funds £ 79,923 |
2024 Total funds £ 96,412 |
|---|---|---|---|---|
| 79,923 94,614 829,811 |
- - - |
79,923 94,614 829,811 |
96,412 34,316 862,318 |
|
| 924,425 (12,115) |
- - |
924,425 (12,115) |
896,634 (28,315) |
|
| 912,310 | - | 912,310 | 868,319 | |
| 992,233 | - | 992,233 | 964,731 | |
| 992,233 | - | 992,233 | 964,731 | |
| 992,233 | 964,731 | |||
| 992,233 | 964,731 |
On behalf of the board
Mr A D Hill Trustee 21 September 2026
The notes on pages 14 to 22 form part of these financial statements.
Page 12
Prostate Cymru Statement of Cash Flows For The Year Ended 31 December 2025
| Notes Cash flows from operating activities Net cash used in operations 1 Net cash used in operating activities Cash flows from investing activities Proceeds from disposal of tangible assets Interest received Net cash generated from investing activities Decrease in cash and cash equivalents Cash and cash equivalents at beginning of year 2 Cash and cash equivalents at end of year 2 |
2025 £ (39,366) (39,366) (6,242) 13,101 6,859 (32,507) 862,318 829,811 |
2024 £ (19,225) |
|---|---|---|
| (19,225) | ||
| - 14,578 |
||
| 14,578 | ||
| (4,647) 866,965 |
||
| 862,318 |
Page 13
Prostate Cymru Notes to the Statement of Cash Flows For The Year Ended 31 December 2025
1. Reconciliation of income/(expenditure) to cash used in operations
| 1. Reconciliation of income/(expenditure) to cash used in operations |
||
|---|---|---|
| Net income/(expenditure) Adjustments for: Interest income Amortisation of intangible assets Depreciation of tangible assets Movements in working capital: (Increase)/decrease in trade and other debtors (Decrease)/increase in trade and other creditors Net cash used in operations |
2025 £ 27,502 (13,101) - 22,731 (60,298) (16,200) (39,366) |
2024 £ (47,300) (14,578) 2,500 16,584 11,151 12,418 |
| (19,225) |
2. Cash and cash equivalents
Cash and cash equivalents, as stated in the Statement of Cash Flows, relates to the following items in the Balance Sheet:
| 2025 £ Cash at bank and in hand 829,811 3. Analysis of changes in net funds As at 1 January 2025 Cash flows £ £ Cash at bank and in hand 862,318 (32,507) |
2024 £ 862,318 |
|---|---|
| As at 31 December 2025 £ 829,811 |
Page 14
Prostate Cymru Notes to the Financial Statements For The Year Ended 31 December 2025
1. General Information
Prostate Cymru is a charitable incorporated organisation registered with the Charity Commission, registered charity number 1168682. The principal address is 12, Drake Walk, Waterfront 2000, Cardiff, CF10 4AN.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared in accordance with the Charities SORP (FRS 102) "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)", Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Charities Act 2011.
The charity is a Public Benefit Entity as defined by FRS 102.
2.2. Going Concern Disclosure
At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.
2.3. Fund Accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.
Designated funds comprise unrestricted funds that have been set aside by the trustees for a specific purpose.
Restricted funds are to be used for specific purposes as laid down by the donor.
Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.
2.4. Incoming Resources
Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.
Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.
Donated services and facilities are included in the SoFA when received at the value of the gift to the charity provided the value of the gift can be measured reliably. Donated services and facilities that are consumed immediately are recognised as income with an equivalent amount recognised as an expense under the appropriate heading in the SoFA.
Event and fundraising income is credited to the Statement of Financial Activities in the period to which the event is due to take place.
Grants are only included in the SoFA when the general income recognition criteria are met.
In the case of performance related grants, income must only be recognised to the extent that the charity has provided the specified goods or services, as entitlement to the grant only occurs when the performance related conditions are met. Grants receivable are treated in different ways dependent upon their purposes and the terms of the grant.
Grants receivable for specific purposes are also treated as restricted funds so that any unused funds can be separately identified.
The value of any voluntary help received is not included in the accounts but is described in the trustees' annual report.
Page 15
Prostate Cymru Notes to the Financial Statements (continued) For The Year Ended 31 December 2025
2.5. Resources Expended
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably.
Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges are allocated on the portion of the asset’s use.
Expenditure is recognised once there is a legal or constructive obligation to make a payment to a third party, it is probable that settlement will be required and the amount of the obligation can be measured reliably.
Costs of raising funds comprise the costs in relation to generating income such as fundraising activities.
Expenditure on charitable activities includes all costs relating to the furtherance of the charity's objectives as stated in the trustees report and their associated support costs.
Support costs have been allocated between governance costs and other support. Support costs included central functions and have been allocated to activity cost categories on a basis consistent with the use of resources.
Governance costs comprise all costs involving public accountability of the charity and its compliance with regulation and good practice.
Irrecoverable VAT is charged as a cost against the activity for which the expenditure was incurred.
2.6. Intangible Fixed Assets and Amortisation - Other Intangible
Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.
Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Software - 20% straight line
2.7. Tangible Fixed Assets and Depreciation
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Motor Vehicles 20% reducing balance Fixtures & Fittings 20% straight line Computer Equipment 33% straight line
At each reporting end date, the charity reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).
2.8. Cash and Cash Equivalents
Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks, other short-term highly liquid investments that mature in no more than three months from the date of acquisition and are readily convertible to a known amount of cash with insignificant risk of change in value, and bank overdrafts.
2.9. Pensions
The charity operates a defined pension contribution scheme. Contributions are charged to the Statement of Financial Activities as they become payable in accordance with the rules of the scheme.
Page 16
Prostate Cymru Notes to the Financial Statements (continued) For The Year Ended 31 December 2025
2.10. Cash and cash equivalents
Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
3. Income from Donations and Legacies
| Donations and gifts Gift aid . Income from Other Trading Activities Fundraising events . Investment Income Bank interest receivable . Net Income/(Expenditure) he net income/(expenditure) is stated after charging/(crediting): Depreciation of tangible fixed assets - owned Amortisation of intangible fixed assets |
2025 Unrestricted funds £ 370,276 35,517 |
2024 Unrestricted funds £ 270,902 24,572 |
|---|---|---|
| 405,793 | 295,474 | |
| 2025 Unrestricted funds £ 378,119 |
2024 Unrestricted funds £ 204,621 |
|
| 2025 Unrestricted funds £ 13,101 |
2024 Unrestricted funds £ 14,578 |
|
| 2025 £ 22,731 - |
2024 £ 16,584 2,500 |
4. Income from Other Trading Activities
- Investment Income
6. Net Income/(Expenditure)
The net income/(expenditure) is stated after charging/(crediting):
Page 17
Prostate Cymru Notes to the Financial Statements (continued) For The Year Ended 31 December 2025
7. Analysis of Expenditure
| . Analysis of Expenditure |
||||
|---|---|---|---|---|
| Raising funds Health and research activities Raising funds Health and research activities |
Activities undertaken directly (see note 8) £ 180,424 500,679 |
Grant funding of activities (see note 9) £ - 60,000 |
Support costs (see note 10) £ - 28,408 |
2025 Total £ 180,424 589,087 |
| 681,103 | 60,000 | 28,408 | 769,511 | |
| Activities undertaken directly (see note 8) £ 135,903 359,041 |
Grant funding of activities (see note 9) £ - 45,000 |
Support costs (see note 10) £ - 22,029 |
2024 Total £ 135,903 426,070 |
|
| 494,944 | 45,000 | 22,029 | 561,973 |
8. Direct Costs
| . Direct Costs |
|||
|---|---|---|---|
| Fundraising activities Employee costs Premises expenses General administration Depreciation Fundraising activities Employee costs Premises expenses General administration Depreciation |
Raising funds £ 120,518 59,906 - - - |
Health and research activities £ - 113,957 47,354 316,637 22,731 |
2025 Total £ 120,518 173,863 47,354 316,637 22,731 |
| 180,424 | 500,679 | 681,103 | |
| Raising funds £ 83,025 52,878 - - - |
Health and research activities £ - 97,996 28,517 213,444 19,084 |
2024 Total £ 83,025 150,874 28,517 213,444 19,084 |
|
| 135,903 | 359,041 | 494,944 |
Page 18
Prostate Cymru Notes to the Financial Statements (continued) For The Year Ended 31 December 2025
9. Grants Payable
| 9. Grants Payable |
|||
|---|---|---|---|
| Health and research activities Grants paid to institutions, included above, are as follows: Swansea Bay University Health Board 10. Support Costs Employee costs Premises expenses General administration Governance costs 11. Independent Examiner's Remuneration Independent examination of the financial statements 12. Staff Costs Staff costs were as follows: Wages and salaries Social security costs Other pension costs |
2025 Grants to Institutions £ 60,000 |
2024 Grants to Institutions £ 45,000 |
|
| 2025 £ 60,000 |
2024 £ 45,000 |
||
| 2025 Health and research activities £ 11,273 3,218 13,417 500 |
2024 Health and research activities £ 9,057 3,169 5,963 3,840 |
||
| 28,408 | 22,029 | ||
| 2025 £ 500 2025 £ 159,295 6,098 3,109 168,502 |
2024 £ 3,840 |
||
| 2024 £ 134,920 5,420 2,493 |
|||
| 142,833 |
No employees received employee benefits (excluding employer pension costs) for the reporting period of more than £60,000.
Key management personnel
The gross benefits received by key management personnel totalled £90,018 (2024: £82,142)
13. Average Number of Employees
Average number of employees during the year was: 7 (2024: 11)
Page 19
Prostate Cymru Notes to the Financial Statements (continued) For The Year Ended 31 December 2025
14. Intangible Assets
| Cost As at 1 January 2025 As at 31 December 2025 Amortisation As at 1 January 2025 As at 31 December 2025 Net Book Value As at 31 December 2025 As at 1 January 2025 |
Other £ 30,000 |
|---|---|
| 30,000 | |
| 30,000 | |
| 30,000 | |
| - | |
| - |
15. Tangible Assets
| Cost As at 1 January 2025 Disposals As at 31 December 2025 Depreciation As at 1 January 2025 Provided during the period As at 31 December 2025 Net Book Value As at 31 December 2025 As at 1 January 2025 6. Debtors Due within one year Other debtors |
Motor Vehicles £ 122,090 - |
Fixtures & Fittings £ 4,260 - |
Computer Equipment £ 13,969 6,242 |
Total £ 140,319 6,242 |
|---|---|---|---|---|
| 122,090 | 4,260 | 20,211 | 146,561 | |
| 28,488 18,720 |
4,058 202 |
11,361 3,809 |
43,907 22,731 |
|
| 47,208 | 4,260 | 15,170 | 66,638 | |
| 74,882 | - | 5,041 | 79,923 | |
| 93,602 | 202 | 2,608 | 96,412 | |
| 2025 £ 94,614 |
2024 £ 34,316 |
- Debtors
Page 20
Prostate Cymru Notes to the Financial Statements (continued) For The Year Ended 31 December 2025
17. Creditors: Amounts Falling Due Within One Year
| Trade creditors Other creditors Taxation and social security Accruals and deferred income |
2025 £ 5,797 835 4,983 500 12,115 |
2024 £ 6,360 - 2,717 19,238 |
|---|---|---|
| 28,315 |
18. Pension Commitments
The charity operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the charity in an independently administered fund.
During the year the charge to the statement of financial activities in respect of defined contribution schemes was £3,109 (2024: £2,493).
At the statement of financial position date contributions of £835 (2024: £0) were due to the fund and are included in creditors.
19. Movement in Funds
| Unrestricted funds General: General unrestricted fund Designated: Research and Innovation Grants Support of NHS training, services and equipment Welsh student bursaries Fixed assets PSA Tests Total unrestricted funds Total funds Unrestricted funds General: General unrestricted fund Designated: Research and Innovation Grants |
As at 1 January 2025 £ 489,911 37,313 123,095 63,000 96,412 155,000 |
Income £ 797,013 - - - - - |
Expenditure £ (495,714) - (60,000) (36,066) (22,731) (155,000) |
Transfers £ (446,242) 20,000 310,000 10,000 6,242 100,000 |
As at 31 December 2025 £ 344,968 57,313 373,095 36,934 79,923 100,000 |
|---|---|---|---|---|---|
| 474,820 | - | (273,797) | 446,242 | 647,265 | |
| 964,731 | 797,013 | (769,511) | - | 992,233 | |
| 964,731 | 797,013 | (769,511) | - | 992,233 | |
| As at 1 January 2024 £ 754,247 37,313 |
Income £ 514,673 - |
Expenditure £ (474,009) - |
Transfers £ (305,000) - |
As at 31 December 2024 £ 489,911 37,313 ...CONTINUED |
Page 21
Prostate Cymru Notes to the Financial Statements (continued) For The Year Ended 31 December 2025
| Support of NHS training, services and equipment Welsh student bursaries Fixed assets PSA Tests Total unrestricted funds Restricted funds Welsh Student Bursaries Total funds |
40,435 63,000 115,496 - |
- - - - |
(37,340) (30,000) (19,084) - |
120,000 30,000 - 155,000 |
123,095 63,000 96,412 155,000 |
|---|---|---|---|---|---|
| 256,244 | - | (86,424) | 305,000 | 474,820 | |
| 1,010,491 | 514,673 | (560,433) | - | 964,731 | |
| 1,540 | - | (1,540) | - | - | |
| 1,012,031 | 514,673 | (561,973) | - | 964,731 |
Research and innovation grants
This fund has been designated to provide successful applicants with a grant to enable them to undertake research and to provide successful applicants with innovation bursaries.
Support of NHS training, services and equipment
This fund has been designated to work closely with the Welsh Urological Society in Wales and the Urology Departments at Welsh NHS Hospitals to support training, services and equipment, for example Green Light Laser and training of surgeons on the Da Vinci robot.
Welsh student bursaries
This fund has been designated to help medical students specialising in urology fund their elective studies. An elective is a placement in which the student chooses the content and setting of their studies. The transfer is relating to bursaries paid during the year.
Fixed assets
The fund represents the functional tangible and intangible fixed assets used to further the charity's aims. The transfer relates to the fixed asset additions during the year, which includes the amount transferred from restricted funds towards the purchase of the van.
PSA Tests
This fund has been designated towards the PSA testing project.
20. Transactions with Trustees
None of the trustees received any remuneration or any other benefits from an employment with the charity or a related entity during the current or previous year.
During the year the expenses reimbursed to the trustees or paid directly to third parties were as follows:
| Travel Other Expenses |
2025 £ 422 2,078 |
2024 £ 1,012 - |
|---|---|---|
| 2,500 | 1,012 |
During the year the charity has purchased a laptop for use by the Trustees when conducting work on behalf of the charity.
21. Related Party Disclosures
There have been no related party transactions in the reporting period that require disclosure, except for those disclosed in the Transactions with Trustees note.
Page 22